Spectrum Pharmaceuticals News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

20.07.23	Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote "FOR” Proposed Transaction with Assertio Holdings, Inc. (Businesswire)
03.07.23	IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, ASRT, MDWT, SPPI (PR Newswire)
17.05.23	Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement (Businesswire)
09.05.23	Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update (Businesswire)
02.05.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, NATI, SPPI (PR Newswire)
27.04.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, SPPI, HOTH (PR Newswire)
25.04.23	Assertio Holdings To Acquire Spectrum Pharmaceuticals; ASRT Stock Tumble In Pre-market (RTTNews)
22.03.23	Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update (Businesswire)
17.03.23	Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update (Businesswire)
08.02.23	Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services (Businesswire)
02.02.23	SPPI FINAL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - SPPI (PR Newswire)
31.01.23	Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results (Businesswire)
26.01.23	ROSEN, NATIONAL TRIAL LAWYERS, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI (PR Newswire)
26.01.23	Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff (Businesswire)
18.01.23	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action- SPPI (PR Newswire)
11.01.23	ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action- SPPI (PR Newswire)
04.01.23	Spectrum Pharmaceuticals Announces Management Changes (Businesswire)
04.01.23	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action- SPPI (PR Newswire)
27.12.22	ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPPI (PR Newswire)
27.12.22	Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff (Businesswire)
21.12.22	ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI (PR Newswire)
14.12.22	SPPI INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI (PR Newswire)
06.12.22	Spectrum Pharmaceuticals’ ROLVEDON™ (eflapegrastim-xnst) Injection Added to NCCN Supportive Care Guidelines in Oncology for Hematopoietic Growth Factors (Businesswire)
05.12.22	Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff (Businesswire)
25.11.22	FDA Rejects Spectrum's Poziotinib, As Expected, Company To Cut R&D Workforce By 75% (RTTNews)
25.11.22	Spectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib; Reaffirms Focus on the Commercialization of ROLVEDON™ (eflapegrastim-xnst) injection (Businesswire)
10.11.22	Spectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update (Businesswire)
03.11.22	Spectrum Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update (Businesswire)
01.11.22	ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - SPPI (PR Newswire)
26.10.22	Biotech Stocks Facing FDA Decision In November 2022 (RTTNews)
21.10.22	Spectrum's Rolvedon Injection Ready To Sell Into Estimated $2 Bln Market (RTTNews)
21.10.22	Spectrum Pharmaceuticals Announces Commercial Availability of ROLVEDON™ (eflapegrastim-xnst) Injection (Businesswire)
23.09.22	Spectrum Pharmaceuticals Announces Debt Financing Agreement with SLR Capital Partners with $30 Million Funded at Closing (Businesswire)
22.09.22	Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting (Businesswire)
10.09.22	Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022 (Businesswire)
09.09.22	Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection (Businesswire)
05.09.22	Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2022 (Businesswire)
27.08.22	Biotech Stocks Facing FDA Decision In September (RTTNews)
11.08.22	Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update (Businesswire)
29.07.22	Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update (Businesswire)
02.06.22	Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences (Businesswire)
26.05.22	Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response (Businesswire)
17.05.22	Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference (Businesswire)
12.05.22	Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update (Businesswire)
11.05.22	Spectrum Pharma Names Nora Brennan CFO - Quick Facts (RTTNews)
11.05.22	Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer (Businesswire)
06.05.22	Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update (Businesswire)
05.05.22	Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors (Businesswire)
11.04.22	Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim (Businesswire)
04.04.22	Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.32	1.80 %	K V
UBS Group	28.00	1.19 %	K V
Part Grp Hldg	1’265.50	0.92 %	K V
Geberit	527.20	0.65 %	K V
Swiss Re	129.45	0.58 %	K V
Alcon	77.84	-0.21 %	K V
Nestle	76.20	-0.21 %	K V
CieFinRichemont	121.25	-0.53 %	K V
Sonova Hldg	301.10	-0.95 %	K V
Givaudan	3’838.00	-1.08 %	K V